This bill amends various sections of Florida Statutes to enhance the regulation of chemicals in consumer products, particularly focusing on drugs, vaccines, and cosmetics. It revises the definition of "drug" to include food containing a vaccine or vaccine material and introduces a new definition for "vaccine or vaccine material." The bill establishes that a drug is misbranded if it is a food containing a vaccine but lacks proper labeling. Additionally, it mandates that cosmetics sold in Florida must provide public notice of certain added ingredients on a manufacturer-maintained website and prohibits the sale of cosmetics that release formaldehyde unless it is a natural byproduct without functional purpose. The legislation also defines messenger ribonucleic acid (mRNA) vaccines and prohibits the use of fruits and vegetables as delivery mechanisms for these vaccines.

Furthermore, the bill outlines updated regulations for restricted prescription drug distributors, detailing the requirements for obtaining and renewing permits. It specifies that distributions must comply with wholesale distributor regulations and allows the Department of Health to adopt rules for the distribution of prescription drugs by various entities, including hospitals and charitable organizations. Notably, it clarifies that a permit is not required for certain distributions between pharmacies under common ownership in emergency situations. The bill also updates references related to emergency medical reasons and recordkeeping for prescription drug distributions, ensuring alignment with current practices. The act is set to take effect on July 1, 2025.